| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |